We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Protein Atlas Aids Drug Discovery

By Biotechdaily staff writers
Posted on 21 May 2002
The Protein Atlas of the Human Genome is designed to be a new tool for understanding the causes of diseases and for aiding drug delivery and development.

Unlike existing databases that use DNA/RNA information to predict genes and proteins, the proteins themselves are the foundation of the Protein Atlas, says the developer, Confirmant LTD (Abingdon, UK). More...
The information in the atlas was experimentally derived by using proprietary technologies developed by Oxford GlycoSciences to identify protein sequence tags (PSTs) that can be mapped back to the human genome to define gene structure unambiguously. This approach is designed to overcome the inaccuracies associated with computational predictions by providing definitive information needed for the identification, prioritization, and validation of drug targets. The atlas currently contains information about some 7,000 genes, including the protein variants they encode.

"The Protein Atlas is a combined genomics and proteomics approach that has tremendous potential to increase our understanding of disease at a molecular level, and to deliver a substantial productivity boost to drug discovery pipelines,” said Dr. Andrew Lyall, a director of Confirmant. The company is a joint venture formed by two UK firms, Oxford GlycoSciences and Marconi.




Related Links:
Confirmant

New
Gold Member
Automatic Hematology Analyzer
CF9600
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Pipette Calibration System
Artel PCS®
New
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study results show blood protein levels change markedly in childhood and adolescence, with sex differences increasing with age (photo credit: Adobe Stock)

Proteomic Data Underscore Need for Age-Specific Pediatric Reference Ranges

Serum proteins underpin many routine tests used to detect inflammation, hormonal imbalance, cardiovascular disease, and metabolic disorders. Yet pediatric interpretation often relies on adult reference... Read more

Pathology

view channel
Image: Study flowchart. This study developed a multimodal artificial intelligence framework to predict PIK3CA mutations in breast cancer (Jiaxian Miao et al., Cancer Biol Med 23(3): 430–450 (2026). DOI: 10.20892/j.issn.2095-3941.2025.0771)

Multimodal AI Tool Predicts Genetic Alterations to Guide Breast Cancer Treatment

PIK3CA mutations are key biomarkers for selecting phosphoinositide 3-kinase (PI3K)–targeted therapies in breast cancer, yet access to molecular testing can be inconsistent and costly. Conventional polymerase... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.